单细胞多组学揭示了CPS1作为乳腺癌免疫逃避治疗点
Jian Yue1, Fang Wen2, Dele He3
1Department of Breast Surgery, Gaozhou People's Hospital, Gaozhou, 525200, China.
这项研究引入了MitoScore,一种使用线粒体基因预测乳腺癌患者风险和指导个性化治疗的新系统. 向CPS1显示了通过减少瘤免疫抑制来改善免疫治疗的希望.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 免疫学 免疫学 免疫学
背景情况:
- 乳腺癌仍然是全球主要的死亡原因,预后工具有限.
- 乳腺癌现有的预后特征往往缺乏预测能力和临床实用性.
研究的目的:
- 研究线粒体基因组在乳腺癌 (BRCA) 中的临床相关性.
- 开发一个预后评分系统 (MitoScore) 用于患者分层和确定治疗目标.
主要方法:
- 在TCGA-BRCA和GEO数据集上进行集成的单细胞多omics分析和机器学习.
- 开发和验证MitoScore系统的使用.
- 免疫透,细胞间通信,以及以CPS1.1为重点的体外/体内实验.
主要成果:
- MitoScore有效地将BRCA患者分为高风险和低风险组,具有不同的预后.
- 高风险患者表现出免疫抑制瘤微环境和异常的MIF-CXCR4信号传递.
- 已确定CPS1是关键的与代谢相关的瘤基因,驱动葡萄糖分解和免疫逃避,对预后不佳至关重要.
结论:
- 线粒体基因在BRCA中具有显著的临床重要性,MitoScore提供了精确的患者分层.
- CPS1是一种潜在的治疗点,可以同时解决乳腺癌中的代谢重编程和免疫逃避.
- 向CPS1可以通过调节瘤微环境来增强抗PD-1疗法的有效性并改善患者的存活率.
更多相关视频
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
相关概念视频
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Abnormal Proliferation
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
